Is Bellamy's Australia Ltd a stand-out BUY right now?

Bellamy's Australia Ltd (ASX:BAL) shares been under serious pressure in 2016, but can this market darling bounce back?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There is no doubt that Bellamy's Australia Ltd (ASX: BAL) was a superstar stock in 2015 and became an instant market darling for many investors.

The shares started 2015 at around $1.69 a share and ended up closer towards $16.50 by the end of the year – a monster gain of 876%.

It has been a contrasting story in 2016, however, with the shares losing around 35% of their value since hitting that high of $16.50 in late 2015.

While it would be normal to expect the shares to take a breather after such a strong performance, there is, nevertheless, a number of factors that have seen the shares become surprisingly volatile over the past few months. This despite the company confirming several times that it would generate full year sales of between $240 million and $260 million.

Five factors that I think have had the biggest negative impact on the infant food company's share price include:

Changes to Chinese regulations – This has perhaps been the single biggest issue facing Bellamy's and a number of other companies in the sector that sell a significant proportion of goods into China. Bellamy's is confident, however, that these new taxes are unlikely to impact the demand for Bellamy's products and that Chinese consumers will be able to easily absorb any price increases as they have done so in the past. Nevertheless, there has been anecdotal evidence that suggests shipments of goods are being delayed at Chinese customs and that some local courier companies have delayed making deliveries into China.

Increasing levels of competition – The global baby formula market is growing at around 7% a year and is expected to increase even further following the official ending of China's one-child policy. As a result, new players are entering the market in a bid to grab a slice of the action and established players like a2 Milk Company Ltd (Australia) (ASX: A2M) are ramping up their production levels to take advantage of the growth.

Flat second half margins – In its first half results, Bellamy's recorded sales of $105.1 million and forecast second half sales of between $134.9 million – $ $154.9 million. While this level of sales growth in the second half would be impressive, investors have been concerned that management expects second half EBIT margins to remain the same as the first half.

Stretched valuation – According to CommSec, Bellamy's is expected to deliver FY16 earnings per share (EPS) of 23.5 cents. I think this is a little on the low side considering the company recorded first half EPS of 13.9 cents. Nevertheless, even if the company generates full year EPS of 30 cents, the company is still trading on more than 35x estimated earnings. At $16.50, it was trading on 55x estimated earnings. When companies trade on such high valuations, even the slightest change in sentiment will have a huge impact on the share price.

Increased short selling – It might be hard for some investors to believe, but Bellamy's is now the 11th most shorted stock on the ASX with around 8.6% of all shares currently short sold. As the graph below highlights, there has been a huge spike in short positions starting at the same time the share price started to fall.

Source: www.shortman.com.au
Source: www.shortman.com.au

The increased level of short selling has coincided with weakness in the share price, but the bigger concern for investors is that short positions have continued to climb over the last month. Short sellers are usually very well informed and some investors might now be asking whether or not there could be more downside risk from here.

Foolish takeaway

There is no doubt Bellamy's is a quality company, but at the end of the day it comes back to what somebody is prepared to pay to own it. I'm not totally convinced that the shares are offering a good enough risk-reward proposition to be a standout buy, but I would definitely consider buying if the valuation became more attractive than it currently is.

Motley Fool contributor Christopher Georges has no position in any stocks mentioned. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »